Does TRIAMCINOLONE Cause Mobility decreased? 373 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 373 reports of Mobility decreased have been filed in association with TRIAMCINOLONE. This represents 5.6% of all adverse event reports for TRIAMCINOLONE.
373
Reports of Mobility decreased with TRIAMCINOLONE
5.6%
of all TRIAMCINOLONE reports
139
Deaths
305
Hospitalizations
How Dangerous Is Mobility decreased From TRIAMCINOLONE?
Of the 373 reports, 139 (37.3%) resulted in death, 305 (81.8%) required hospitalization, and 167 (44.8%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRIAMCINOLONE. However, 373 reports have been filed with the FAERS database.
What Other Side Effects Does TRIAMCINOLONE Cause?
Drug ineffective (3,035)
Psoriasis (1,131)
Off label use (901)
Product use in unapproved indication (724)
Condition aggravated (625)
Therapeutic product effect incomplete (624)
Treatment failure (612)
Drug intolerance (527)
Nausea (525)
Pruritus (485)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which TRIAMCINOLONE Alternatives Have Lower Mobility decreased Risk?
TRIAMCINOLONE vs TRIAMCINOLONE ACETONIDE
TRIAMCINOLONE vs TRIAMCINOLONE HEXACETONIDE
TRIAMCINOLONE vs TRIAMTERENE
TRIAMCINOLONE vs TRIATEC
TRIAMCINOLONE vs TRIAZOLAM